Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02658734
Brief Title: A Study of Trastuzumab Emtansine in Indian Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Unresectable Locally Advanced or Metastatic Breast Cancer Who Have Received Prior Treatment With Trastuzumab and a Taxane

First Submitted : January 15, 2016
First Submitted that Met QC Criteria : January 19, 2016
First Posted : January 20, 2016 (Estimate)

Results First Submitted : December 10, 2020
Results First Submitted that Met QC Criteria : January 21, 2021
Results First Posted : February 9, 2021

Last Update Submitted that Met QC Criteria : January 21, 2021
Last Update Posted : February 9, 2021